Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1991-12-03
1993-06-15
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
052198898
ABSTRACT:
A method for supplementing dietary potassium, magnesium and citrate is disclosed that comprises orally administering an effective amount of potassium magnesium citrate in a single salt. Methods for decreasing urinary calcium and oxalate by the administration of potassium magnesium citrate in a single salt are also disclosed.
REFERENCES:
patent: 3086928 (1963-04-01), Schulz
patent: 4738856 (1988-04-01), Clark
patent: 4895980 (1990-01-01), Walsdorf et al.
patent: 4985593 (1991-01-01), Walsdorf et al.
Avery's Drug Treatment, 3rd ed. (1987) pp. 643-648.
Yendt, E. R. et al. 1978. "Prevention of Calcium Stones With Thiazides", Kidney International, vol. 13, pp. 397-409.
Nicar, M. J. et al. 1984. "Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis". The Journal of Urology, vol. 131.
Rudman, D. et al. 1980. "Hypocitraturia in Patients With Gastrointestinal Malabsorption". The New England Journal of Medicine, vol. 303, pp. 657-661.
Pak, C. Y. C. 1987. "Citrate and Renal Calculi". Mineral and Electrolyte Metabolism, vol. 13, pp. 257-266.
Pak, C. Y. C. et al. 1985. "Correction of Hypocitraturia and Prevention of Stone Formation by Combined Thiazide and Potassium Citrate Therapy in Thiazide-Unresponsive Hypercalciuric Nephrolithiasis". The American Journal of Medicine, vol. 79, pp. 284-288.
Barilla, D. E. et al. 1978. "Renal Oxalate Excretion Following Oral Oxalate Loads in Patients with Ileal Disease and with Renal and Absorptive Hypercalciurias". The American Journal of Medicine, vol. 64, pp. 579-585.
Sakhaee, K. et al. 1983. "Contrasting Effects of Potassium Citrate and Sodium Citrate Therapies on Urinary Chemistries and Crystallization of Stone-Forming Salts", Kidney International, vol. 24, pp. 348-352.
Pak, C. Y. C. et al. 1985. "Long-Term Treatment of Calcium Nephrolithiasis With Potassium Citrate". The Journal of Urology. vol. 134, pp. 11-19.
Harvey, J. A. et al. 1985. "Calcium Citrate: Reduced Propensity for the Crystallization of Calcium Oxalate in Urine Resulting From Induced Hypercalciuria of Calcium Supplementation". Journal of Clinical Endocrinology and Metabolism. vol. 61, pp. 1223-1225.
Preminger, G. M., et al., 1989. "Hypomagnesiuric Hypocitraturia: An Apparent New Entity for Calcium Nephrolithiasis". Journal of Lithotripsy and Stone Diesase, vol. 1, pp. 22-25.
Putzar, et al. (1979) Chemical Abstracts, vol. 90, No. 56264q.
Alexandrides George
Pak Charles Y. C.
Walsdorf Neill B.
Henley III Raymond J.
Mission Pharmacal Company
The University of Texas System
Waddell Frederick E.
LandOfFree
Dietary supplementation with potassium magnesium citrate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dietary supplementation with potassium magnesium citrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary supplementation with potassium magnesium citrate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1043141